In adults with obesity but without type 2 diabetes, tirzepatide increased weight loss at 72 wk compared with semaglutide. Lesser LI. Ann Intern Med 2025 Nov 4. doi: 10.7326/ANNALS-25-04321.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lesser LI. In adults with obesity but without type 2 diabetes, tirzepatide increased weight loss at 72 wk compared with semaglutide. Ann Intern Med 2025 Nov 4. doi: 10.7326/ANNALS-25-04321.
PMID: 41183340